Report Detail
Global Pediatric ADHD Drugs Market Growth (Status and Outlook) 2022-2028
- RnM4486285 |
- 24 August, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The global market for Pediatric ADHD Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pediatric ADHD Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pediatric ADHD Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pediatric ADHD Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pediatric ADHD Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pediatric ADHD Drugs players cover Pfizer, Johnson & Johnson, Eli Lilly and Company, Tris Pharma and Noven Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pediatric ADHD Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pediatric ADHD Drugs market, with both quantitative and qualitative data, to help readers understand how the Pediatric ADHD Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Pediatric ADHD Drugs market and forecasts the market size by Type (Tablets, Oral Liquid and Other), by Application (Hospital, Retail Pharmacy and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Tablets
Oral Liquid
Other
Segmentation by application
Hospital
Retail Pharmacy
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Pfizer
Johnson & Johnson
Eli Lilly and Company
Tris Pharma
Noven Pharmaceuticals
Alcobra Pharmaceuticals
Novartis
GlaxoSmithKline
Purdue Pharma
Takeda Pharmaceutical
Curemark
Supernus Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Pediatric ADHD Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Pediatric ADHD Drugs market size and CAGR, Pediatric ADHD Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pediatric ADHD Drugs revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pediatric ADHD Drugs revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pediatric ADHD Drugs market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer, Johnson & Johnson, Eli Lilly and Company, Tris Pharma, Noven Pharmaceuticals, Alcobra Pharmaceuticals, Novartis, GlaxoSmithKline and Purdue Pharma, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pediatric ADHD Drugs Market Size 2017-2028
- 2.1.2 Pediatric ADHD Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Pediatric ADHD Drugs Segment by Type
- 2.2.1 Tablets
- 2.2.2 Oral Liquid
- 2.2.3 Other
- 2.3 Pediatric ADHD Drugs Market Size by Type
- 2.3.1 Pediatric ADHD Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Pediatric ADHD Drugs Market Size Market Share by Type (2017-2022)
- 2.4 Pediatric ADHD Drugs Segment by Application
- 2.4.1 Hospital
- 2.4.2 Retail Pharmacy
- 2.4.3 Other
- 2.5 Pediatric ADHD Drugs Market Size by Application
- 2.5.1 Pediatric ADHD Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Pediatric ADHD Drugs Market Size Market Share by Application (2017-2022)
3 Pediatric ADHD Drugs Market Size by Player
- 3.1 Pediatric ADHD Drugs Market Size Market Share by Players
- 3.1.1 Global Pediatric ADHD Drugs Revenue by Players (2020-2022)
- 3.1.2 Global Pediatric ADHD Drugs Revenue Market Share by Players (2020-2022)
- 3.2 Global Pediatric ADHD Drugs Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pediatric ADHD Drugs by Regions
- 4.1 Pediatric ADHD Drugs Market Size by Regions (2017-2022)
- 4.2 Americas Pediatric ADHD Drugs Market Size Growth (2017-2022)
- 4.3 APAC Pediatric ADHD Drugs Market Size Growth (2017-2022)
- 4.4 Europe Pediatric ADHD Drugs Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Pediatric ADHD Drugs Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Pediatric ADHD Drugs Market Size by Country (2017-2022)
- 5.2 Americas Pediatric ADHD Drugs Market Size by Type (2017-2022)
- 5.3 Americas Pediatric ADHD Drugs Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Pediatric ADHD Drugs Market Size by Region (2017-2022)
- 6.2 APAC Pediatric ADHD Drugs Market Size by Type (2017-2022)
- 6.3 APAC Pediatric ADHD Drugs Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Pediatric ADHD Drugs by Country (2017-2022)
- 7.2 Europe Pediatric ADHD Drugs Market Size by Type (2017-2022)
- 7.3 Europe Pediatric ADHD Drugs Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Pediatric ADHD Drugs by Region (2017-2022)
- 8.2 Middle East & Africa Pediatric ADHD Drugs Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Pediatric ADHD Drugs Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Pediatric ADHD Drugs Market Forecast
- 10.1 Global Pediatric ADHD Drugs Forecast by Regions (2023-2028)
- 10.1.1 Global Pediatric ADHD Drugs Forecast by Regions (2023-2028)
- 10.1.2 Americas Pediatric ADHD Drugs Forecast
- 10.1.3 APAC Pediatric ADHD Drugs Forecast
- 10.1.4 Europe Pediatric ADHD Drugs Forecast
- 10.1.5 Middle East & Africa Pediatric ADHD Drugs Forecast
- 10.2 Americas Pediatric ADHD Drugs Forecast by Country (2023-2028)
- 10.2.1 United States Pediatric ADHD Drugs Market Forecast
- 10.2.2 Canada Pediatric ADHD Drugs Market Forecast
- 10.2.3 Mexico Pediatric ADHD Drugs Market Forecast
- 10.2.4 Brazil Pediatric ADHD Drugs Market Forecast
- 10.3 APAC Pediatric ADHD Drugs Forecast by Region (2023-2028)
- 10.3.1 China Pediatric ADHD Drugs Market Forecast
- 10.3.2 Japan Pediatric ADHD Drugs Market Forecast
- 10.3.3 Korea Pediatric ADHD Drugs Market Forecast
- 10.3.4 Southeast Asia Pediatric ADHD Drugs Market Forecast
- 10.3.5 India Pediatric ADHD Drugs Market Forecast
- 10.3.6 Australia Pediatric ADHD Drugs Market Forecast
- 10.4 Europe Pediatric ADHD Drugs Forecast by Country (2023-2028)
- 10.4.1 Germany Pediatric ADHD Drugs Market Forecast
- 10.4.2 France Pediatric ADHD Drugs Market Forecast
- 10.4.3 UK Pediatric ADHD Drugs Market Forecast
- 10.4.4 Italy Pediatric ADHD Drugs Market Forecast
- 10.4.5 Russia Pediatric ADHD Drugs Market Forecast
- 10.5 Middle East & Africa Pediatric ADHD Drugs Forecast by Region (2023-2028)
- 10.5.1 Egypt Pediatric ADHD Drugs Market Forecast
- 10.5.2 South Africa Pediatric ADHD Drugs Market Forecast
- 10.5.3 Israel Pediatric ADHD Drugs Market Forecast
- 10.5.4 Turkey Pediatric ADHD Drugs Market Forecast
- 10.5.5 GCC Countries Pediatric ADHD Drugs Market Forecast
- 10.6 Global Pediatric ADHD Drugs Forecast by Type (2023-2028)
- 10.7 Global Pediatric ADHD Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Pfizer Company Information
- 11.1.2 Pfizer Pediatric ADHD Drugs Product Offered
- 11.1.3 Pfizer Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Pfizer Main Business Overview
- 11.1.5 Pfizer Latest Developments
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Information
- 11.2.2 Johnson & Johnson Pediatric ADHD Drugs Product Offered
- 11.2.3 Johnson & Johnson Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Johnson & Johnson Main Business Overview
- 11.2.5 Johnson & Johnson Latest Developments
- 11.3 Eli Lilly and Company
- 11.3.1 Eli Lilly and Company Company Information
- 11.3.2 Eli Lilly and Company Pediatric ADHD Drugs Product Offered
- 11.3.3 Eli Lilly and Company Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Eli Lilly and Company Main Business Overview
- 11.3.5 Eli Lilly and Company Latest Developments
- 11.4 Tris Pharma
- 11.4.1 Tris Pharma Company Information
- 11.4.2 Tris Pharma Pediatric ADHD Drugs Product Offered
- 11.4.3 Tris Pharma Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Tris Pharma Main Business Overview
- 11.4.5 Tris Pharma Latest Developments
- 11.5 Noven Pharmaceuticals
- 11.5.1 Noven Pharmaceuticals Company Information
- 11.5.2 Noven Pharmaceuticals Pediatric ADHD Drugs Product Offered
- 11.5.3 Noven Pharmaceuticals Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Noven Pharmaceuticals Main Business Overview
- 11.5.5 Noven Pharmaceuticals Latest Developments
- 11.6 Alcobra Pharmaceuticals
- 11.6.1 Alcobra Pharmaceuticals Company Information
- 11.6.2 Alcobra Pharmaceuticals Pediatric ADHD Drugs Product Offered
- 11.6.3 Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Alcobra Pharmaceuticals Main Business Overview
- 11.6.5 Alcobra Pharmaceuticals Latest Developments
- 11.7 Novartis
- 11.7.1 Novartis Company Information
- 11.7.2 Novartis Pediatric ADHD Drugs Product Offered
- 11.7.3 Novartis Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Novartis Main Business Overview
- 11.7.5 Novartis Latest Developments
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Company Information
- 11.8.2 GlaxoSmithKline Pediatric ADHD Drugs Product Offered
- 11.8.3 GlaxoSmithKline Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 GlaxoSmithKline Main Business Overview
- 11.8.5 GlaxoSmithKline Latest Developments
- 11.9 Purdue Pharma
- 11.9.1 Purdue Pharma Company Information
- 11.9.2 Purdue Pharma Pediatric ADHD Drugs Product Offered
- 11.9.3 Purdue Pharma Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Purdue Pharma Main Business Overview
- 11.9.5 Purdue Pharma Latest Developments
- 11.10 Takeda Pharmaceutical
- 11.10.1 Takeda Pharmaceutical Company Information
- 11.10.2 Takeda Pharmaceutical Pediatric ADHD Drugs Product Offered
- 11.10.3 Takeda Pharmaceutical Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Takeda Pharmaceutical Main Business Overview
- 11.10.5 Takeda Pharmaceutical Latest Developments
- 11.11 Curemark
- 11.11.1 Curemark Company Information
- 11.11.2 Curemark Pediatric ADHD Drugs Product Offered
- 11.11.3 Curemark Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Curemark Main Business Overview
- 11.11.5 Curemark Latest Developments
- 11.12 Supernus Pharmaceuticals
- 11.12.1 Supernus Pharmaceuticals Company Information
- 11.12.2 Supernus Pharmaceuticals Pediatric ADHD Drugs Product Offered
- 11.12.3 Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Supernus Pharmaceuticals Main Business Overview
- 11.12.5 Supernus Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pediatric ADHD Drugs. Industry analysis & Market Report on Pediatric ADHD Drugs is a syndicated market report, published as Global Pediatric ADHD Drugs Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Pediatric ADHD Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
